Interní Med. 2004; 6(1): 6-8

Novinky v diagnostice a léčbě akutních koronárních syndromů

MUDr. Vladimír Karmazín

Keywords: Acute coronary syndrome, coronary disease, myocardial infarction, farmacotherapy, cardiac markers, inflammation, angioplasty, prognosis, angina, risk stratification, atherosclerotic plaque.

Published: December 31, 2004  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Karmazín V. Novinky v diagnostice a léčbě akutních koronárních syndromů. Interní Med. 2004;6(1):6-8.

MUDr. Vladimír Karmazín

Klinika kardiologie IKEM Praha

V přehledném článku shrnujeme současné trendy v diagnostice a léčbě akutních koronárních syndromů s přihlédnutím ke stratifikaci rizika. Spolu s farmakoterapií popisujeme prioritu invazivní strategie spojenou s problematikou transportu do kardiocenter.

Novelties in the diagnosis and treatment of acute coronary syndromes

In this overview we describe contemporary trends in the diagnosis and treatment of acute coronary syndromes in relation with risk stratification. Together with farmacotherapy we describe the priority of invasive strategy in combination with the transport to specialized cardiocenters.

Download citation

References

  1. Berger PB, et al. Clinical implications of percutaneous coronary intervention - clopidogrel in unstable angina to prevent recurrent events (PCI-CURE) Study. Circulation 2002; 106: 2284-2287. Go to original source... Go to PubMed...
  2. Corti R, et al. The vulnerable plaque and acute coronary syndromes. Am J Med. 2002; 113: 668-680. Go to original source... Go to PubMed...
  3. Hrnčárek M. Ambulantní koronarografické vyšetření a navazující koronární intervence u nemocných s akutními koronárními syndromy. Lékařské listy 2002; 45: 6-11.
  4. Kinlay S, et al. High-dose atorvastatin enhances the decline in inflammatory markers in patiens with acute coronary syndromes in the MIRACL study. Circulation 2003; 108: 1560-1566. Go to original source... Go to PubMed...
  5. Morrow DA, et al. Future of biomarkers in acute coronary syndromes. Circulation 2003; 108: 250-252. Go to original source... Go to PubMed...
  6. Rao SV, et al. Prognostic value of isolated troponin elevation across the spektrum of chest pain syndromes. Am J Cardiol 2003; 91: 936-940. Go to original source... Go to PubMed...
  7. Sabatine MS, et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes. Circulation 2002; 105: 1760-1763. Go to original source... Go to PubMed...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.